View in EDS

Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy.

Saved in:
Bibliographic Details
Title: Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy.
Authors: Tong CC; Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA. charles.tong@mssm.edu, Lau KH, Rivera M, Cannan D, Aguirre-Ghiso J, Sikora AG, Gupta V, Forsythe K, Ko EC, Misiukiewicz K, Gurudutt V, Teng MS, Packer SH, Genden EM, Kao J
Source: Oncology reports [Oncol Rep] 2012 May; Vol. 27 (5), pp. 1580-6. Date of Electronic Publication: 2012 Feb 07.
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2431 (Electronic) Linking ISSN: 1021335X NLM ISO Abbreviation: Oncol Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 22322320
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tong+CC%22">Tong CC</searchLink>; Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA. charles.tong@mssm.edu<br /><searchLink fieldCode="AU" term="%22Lau+KH%22">Lau KH</searchLink><br /><searchLink fieldCode="AU" term="%22Rivera+M%22">Rivera M</searchLink><br /><searchLink fieldCode="AU" term="%22Cannan+D%22">Cannan D</searchLink><br /><searchLink fieldCode="AU" term="%22Aguirre-Ghiso+J%22">Aguirre-Ghiso J</searchLink><br /><searchLink fieldCode="AU" term="%22Sikora+AG%22">Sikora AG</searchLink><br /><searchLink fieldCode="AU" term="%22Gupta+V%22">Gupta V</searchLink><br /><searchLink fieldCode="AU" term="%22Forsythe+K%22">Forsythe K</searchLink><br /><searchLink fieldCode="AU" term="%22Ko+EC%22">Ko EC</searchLink><br /><searchLink fieldCode="AU" term="%22Misiukiewicz+K%22">Misiukiewicz K</searchLink><br /><searchLink fieldCode="AU" term="%22Gurudutt+V%22">Gurudutt V</searchLink><br /><searchLink fieldCode="AU" term="%22Teng+MS%22">Teng MS</searchLink><br /><searchLink fieldCode="AU" term="%22Packer+SH%22">Packer SH</searchLink><br /><searchLink fieldCode="AU" term="%22Genden+EM%22">Genden EM</searchLink><br /><searchLink fieldCode="AU" term="%22Kao+J%22">Kao J</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229422756%22">Oncology reports</searchLink> [Oncol Rep] 2012 May; Vol. 27 (5), pp. 1580-6. <i>Date of Electronic Publication: </i>2012 Feb 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22D%2EA%2E+Spandidos%22">D.A. Spandidos </searchLink><i>Country of Publication: </i>Greece <i>NLM ID: </i>9422756 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1791-2431 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221021335X%22">1021335X </searchLink><i>NLM ISO Abbreviation: </i>Oncol Rep <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=22322320
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3892/or.2012.1679
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1580
    Titles:
      – TitleFull: Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tong CC
      – PersonEntity:
          Name:
            NameFull: Lau KH
      – PersonEntity:
          Name:
            NameFull: Rivera M
      – PersonEntity:
          Name:
            NameFull: Cannan D
      – PersonEntity:
          Name:
            NameFull: Aguirre-Ghiso J
      – PersonEntity:
          Name:
            NameFull: Sikora AG
      – PersonEntity:
          Name:
            NameFull: Gupta V
      – PersonEntity:
          Name:
            NameFull: Forsythe K
      – PersonEntity:
          Name:
            NameFull: Ko EC
      – PersonEntity:
          Name:
            NameFull: Misiukiewicz K
      – PersonEntity:
          Name:
            NameFull: Gurudutt V
      – PersonEntity:
          Name:
            NameFull: Teng MS
      – PersonEntity:
          Name:
            NameFull: Packer SH
      – PersonEntity:
          Name:
            NameFull: Genden EM
      – PersonEntity:
          Name:
            NameFull: Kao J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2012 May
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-electronic
              Value: 1791-2431
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Oncology reports
              Type: main
ResultId 1